All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

Indacaterol, A Novel Once Daily Inhaled β2-Adrenoreceptor Agonist

Jorge Roig, * Open Modal , 1 Rosana Hernando2 Ramon Mora Authors Info & Affiliations
The Open Respiratory Medicine Journal • 12 Mar 2009 • RESEARCH ARTICLE • DOI: 10.2174/1874306400903010027

Abstract

In this article we will review the role of long acting β2-adrenoreceptor agonists and long-acting muscarinic agents in the management of airflow obstruction. We will then focus our attention on indacaterol, one of the new once daily inhaled β2-adrenoreceptor agonists. Pharmacologically this drug is a nearly full β2-agonist without loss of efficacy after prolonged administration. We will also discuss its dosing, safety and tolerability.

Keywords: Indacaterol, tachyphylaxis, activity profile, safety..
Fulltext HTML PDF
1800
1801
1802
1803
1804